Pharmaceutical companies are heading toward a steep patent cliff that could strip more than $230 billion in US drug sales ...

Its Herceptin biosimilar nearing launch, Celltrion begins work on Keytruda copySouth Korea’s Celltrion has started work on a biosimilar version of pembrolizumab, Merck & Co’s blockbuster ...

MSD’s checkpoint inhibitor Keytruda has been cleared by the FDA for use in newly diagnosed cervical cancer patients with less severe disease, becoming the first anti-PD-1/PD-L1 immunotherapy for ...

Hundreds of swimmers and volunteers are gearing up to dive in and make waves at the 7th annual Swim Across America – Motor City Mile open water swim on Friday, July 11, 2025, at the Belle Isle ...